These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 3892654

  • 1. Adaptation of the small intestine to induced maldigestion in rats. Experimental pancreatic atrophy and acarbose feeding.
    Creutzfeldt W, Fölsch UR, Elsenhans B, Ballmann M, Conlon JM.
    Scand J Gastroenterol Suppl; 1985; 112():45-53. PubMed ID: 3892654
    [Abstract] [Full Text] [Related]

  • 2. Elevated plasma cholecystokinin concentrations in exocrine pancreatic atrophy in the rat.
    Fölsch UR, Schafmayer A, Ebert R, Becker HD, Creutzfeldt W.
    Digestion; 1984; 29(1):60-4. PubMed ID: 6373466
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inhibition of disaccharide digestion in rat intestine by the alpha-glucosidase inhibitor acarbose (BAY g 5421).
    Krause HP, Keup U, Puls W.
    Digestion; 1982; 23(4):232-8. PubMed ID: 6754513
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of sucrose and Acarbose feeding on the development of streptozotocin-induced diabetes in the rat.
    Goda T, Yamada K, Sugiyama M, Moriuchi S, Hosoya N.
    J Nutr Sci Vitaminol (Tokyo); 1982 Feb; 28(1):41-56. PubMed ID: 6212654
    [Abstract] [Full Text] [Related]

  • 9. Pentagastrin-stimulated gastric acid output and plasma enteroglucagon in acarbose-treated rats.
    Rolston R, Ghiglione M, Bacarese-Hamilton AJ, Uttenthal LO, Bloom SR.
    Digestion; 1985 Feb; 32(2):124-7. PubMed ID: 3899816
    [Abstract] [Full Text] [Related]

  • 10. Response of serum levels of gastric inhibitory polypeptide and insulin to sucrose ingestion during long-term application of acarbose.
    Fölsch UR, Ebert R, Creutzfeldt W.
    Scand J Gastroenterol; 1981 Feb; 16(5):629-32. PubMed ID: 7034156
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Metabolic abnormalities in the genetically obese and diabetic Otsuka Long-Evans Tokushima Fatty rat can be prevented and reversed by alpha-glucosidase inhibitor.
    Yamamoto M, Jia DM, Fukumitsu KI, Imoto I, Kihara Y, Hirohata Y, Otsuki M.
    Metabolism; 1999 Mar; 48(3):347-54. PubMed ID: 10094112
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Reduction of carbohydrate-induced hypertriglyceridemia in (fa,fa) "Zucker" rats by the alpha-glucosidase inhibitor acarbose (BAY g 5421).
    Krause HP, Keup U, Thomas G, Puls W.
    Metabolism; 1982 Jul; 31(7):710-4. PubMed ID: 7045575
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Lysosomal glycogen storage induced by Acarbose, a 1,4-alpha-glucosidase inhibitor.
    Geddes R, Taylor JA.
    Biochem J; 1985 Jun 01; 228(2):319-24. PubMed ID: 3893420
    [Abstract] [Full Text] [Related]

  • 20. Long-term treatment in diabetics with acarbose, a glucosidase inhibitor: efficacy, tolerability and effect on GI hormones.
    Hillebrand I, Aubell R, Boehme K, Bloom SR, Berchtold P.
    Tohoku J Exp Med; 1983 Dec 01; 141 Suppl():683-6. PubMed ID: 6393444
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.